Sabra Health Care REIT stock barely budged after earnings, up just 0.2% to around $20.66, which indicates the market did not see a shock in the headline numbers. The real story sits in the cash engine that matters for any real estate investment trust. Normalized funds from operations per share landed at $0.38, and adjusted funds from operations came in at $0.40, both supported by stronger cash net operating income.

For a stock that has drifted over the past week, this quarter was about demonstrating that managed senior housing growth and rent resets can still influence cash flow.

Love the stable cash flow picture at Sabra Health Care REIT but want more confident balance sheets tied to strong income streams? Take a look at our list of solid balance sheet and fundamentals stocks (49 results).

Q2 2026 Earnings Summary

• Revenue (Q2 2026 vs Q2 2025): US$238.09 million vs. US$189.98 million (higher revenue year over year)
• Net Income/Loss (Q2 2026 vs Q2 2025): loss of US$25.20 million vs. profit of US$65.54 million (moved from profit to loss)
• Basic EPS (Q2 2026 vs Q2 2025): loss of US$0.10 per share vs. profit of US$0.28 per share (moved from earnings to loss)
• Funds From Operations, FFO (Q2 2026 vs Q2 2025): loss of US$5.19 million vs. profit of US$105.30 million (moved from positive to negative FFO)

Prefer clean visuals over scrolling through paragraphs of earnings commentary and spreadsheets? Get a full picture of Sabra Health Care REIT with an at a glance breakdown of its dividend history in the company report for Sabra Health Care REIT.

Sabra bullish thesis meets key cash flow tests

The positive story on Sabra Health Care REIT centers on senior housing and operator upgrades lifting cash NOI and supporting the dividend. Q2 results give that view real footing. Managed senior housing cash NOI moved higher quarter on quarter to US$44.6 million, while total cash NOI reached US$144.3 million, in line with management’s focus on SHOP growth and rent resets. Normalized AFFO per share of US$0.40 covered the US$0.30 dividend at about 75%, matching the income stability narrative rather than stretching payout. Net debt to adjusted EBITDA at 4.61x and roughly US$1.3b of liquidity show the balance sheet is tracking the “solid” description used by bullish analysts. Reaffirmed 2026 guidance and a stronger Avamere rent profile also point to the portfolio repositioning and re-tenanting plan hitting its near term milestones.

Bearish concerns on volatility and credit not dismissed

The cautious view argues that rapid SHOP expansion, re-tenanting and loan issues could inject earnings volatility and strain cash flows at Sabra Health Care REIT. Q2 supports part of that concern. The company booked a US$102.4 million provision for loan losses and other reserves linked to an RCA mortgage resolution. That validates worries about credit and loan renegotiation risk even though the charge is excluded from normalized metrics. Bears also focus on transition risk from the Avamere portfolio. Management still expects a second half operator change with rent stepping further up, so execution risk on occupancy and coverage has not passed. On the other hand, normalized FFO and AFFO both moved higher year over year and the dividend remains covered, which pushes back against fears of immediate payout strain despite higher investment activity and modestly higher interest costs.

Access the multi year analyst estimates for Sabra Health Care REIT to see where the consensus models start to diverge on Sabra Health Care REIT and when analysts think today’s calm share price could meet its next real inflection point.

Take Control Of Your Next Move

If Sabra Health Care REIT’s mix of covered dividends, loan loss provisions and re-tenanting work has your attention, register for free with Simply Wall St and add it to a Watchlist to track the share price against fair value and watch how the thesis develops. Once you decide to take a position, keep your holdings organised with the Portfolio Command Center so you only see the most important updates on cash flow, dividends and balance sheet changes. For a broader view of how other investors are thinking about Sabra Health Care REIT and similar stocks, tap into the Community and compare different perspectives. By surfacing potential catalysts and risks early, you can move faster than the market and make more informed decisions before sentiment shifts.

Seeking Fresh Alternatives Beyond Sabra Health Care REIT

Some stocks are already building breakout momentum while others still fly under the radar for now. Get to them before the crowd catches on and prices move. Act now.

• Spot under the radar compounders with strong balance sheets and growing cash flows by scanning our curated list of solid balance sheet and fundamentals stocks (49 results) before they get fully priced in.
• Ride the next wave of AI momentum by reviewing hand picked 68 profitable AI stocks that aren't just burning cash that already generate real earnings instead of just burning capital on distant promises.
• Target resilient income ideas by filtering for curated 7 dividend fortresses that combine higher yields with businesses built to handle tougher conditions without constant drama.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.